A Review of Next-Generation Therapeutics and Contemporary Management of Myelofibrosis

Goal:,The goal of this activity is to improve knowledge, confidence, and competence of healthcare professionals treating patients with myelofibrosis by leveraging recent and emerging data that must be considered in treatment decisions.,Learning Objectives:,• Develop individualized treatment plans for patients with MF based on risk stratification and burden of symptoms,• Plan evidence-based therapeutic strategies for patients with MF who are relapsed, refractory, or intolerant to prior JAK inhibitor therapy,• Institute best practices for transitioning to a clinically appropriate second-line therapy after first line treatment failure,• Integrate supportive care plans into practice designed to monitor and manage treatment-related toxicities from new or novel MF treatments,• Identify patients with MF who are eligible for enrollment on a clinical trial,Additional details will be posted as soon as information is available.